Decline in Severity of Metabolic Syndrome for U.S. Teens

Share this content:
Decline in Severity of Metabolic Syndrome for U.S. Teens
Decline in Severity of Metabolic Syndrome for U.S. Teens

TUESDAY, Feb. 9, 2016 (HealthDay News) -- For U.S. adolescents, metabolic syndrome (MetS) severity decreased from 1999 to 2012, according to a study published online Feb. 9 in Pediatrics.

Arthur M. Lee, from the University of Virginia in Charlottesville, and colleagues examined temporal trends for 5,117 participants aged 12 to 19 years from the National Health and Nutrition Examination Survey for MetS severity and factors related to diet and physical activity. Individual waves of data from 1999 to 2012 were analyzed.

The researchers found that from 1999 to 2012 there was a linear trend of decreasing MetS in U.S. adolescents (P = 0.030). This was observed in spite of a trend of increasing body mass index z score (P = 0.005). The decline in severity of MetS was attributed to trends in increasing high-density lipoprotein (HDL; P < 0.0001) and decreasing triglyceride levels (P = 0.0001). Over the study period, there was no change in physical activity. Positive associations were seen for total calorie consumption and carbohydrate consumption with HDL levels and negative associations for triglyceride levels; the opposite associations were seen for unsaturated fat consumption. In accordance, trends were noted for decreasing total calorie consumption (P < 0.0001), decreasing carbohydrate consumption (P < 0.0001), and increasing consumption of unsaturated fat (P = 0.002).

"Future studies should investigate the causality of dietary differences on changes in MetS severity in adolescents," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »